HopeStage
Back to all studies
TerminatedNCT00748566

One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome

Medication studyAges 18–65CanadaSchizophrenia
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
Calgary and 31 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateDecember 2008
Recruitment status
Terminated
Enrollment listed in the registry
172
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Sponsor type
Other organization
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Canada
Age range
From 18 Years to 65 Years
Official registry ID
NCT00748566
Official title
Show the full official title

A One-Year, Phase IV, Open-Label, Non-Comparative Trial Of The Effect Of Ziprasidone HCL On Metabolic Syndrome Risk Factors In Patients With Psychotic Disorders

Recruitment & locations

Terminated

Calgary · Medicine Hat · Red Deer

20 more locations
  • Penticton
  • Victoria
  • Winnipeg
  • Bathurst
  • St. John's
  • Halifax
  • Sydney
  • Burlington
  • Chatham
  • Greater Sudbury
  • Kingston
  • London
  • Markham
  • Mississauga
  • Ottawa
  • Toronto
  • Windsor
  • Montreal
  • Verdun
  • Saskatoon

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Does this study involve medication?

Yes. The study involves medication, including Ziprasidone HCL (oral).

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies